Bispecific Antibody Therapy at Memorial Hermann Cancer Center
Sara Taveras Alam, MD, assistant professor of Oncology at McGovern Medical School at UTHealth Houston and an affiliated hematologist/oncologist who oversees treatment at Memorial Hermann Cancer Center – TMC, says that bispecific antibody therapy is a treatment that harnesses the T cells of a patient’s immune system and links them to cancer cells to kill the cancer cells.
Sara Taveras Alam, MD, assistant professor of Oncology at McGovern Medical School at UTHealth Houston and an affiliated hematologist/oncologist who oversees treatment at Memorial Hermann Cancer Center – TMC, says that bispecific antibody therapy is a treatment that harnesses the T cells of a patient’s immune system and links them to cancer cells to kill the cancer cells.